Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...

Kavita Nair, PhD, FAAN, discusses academic medical centers' unique role in diagnosing and managing neurodegenerative diseases ...

NO2 exposure is linked to ovarian cancer, with Mendelian randomization and meta-analysis confirming its role as a risk factor. Nitrogen dioxide (NO 2) is a risk factor for ovarian cancer, according to ...

Her study, "Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes," explores how home health ...

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

A total of 96.9% of the participants had heard of PrEP, of which 90.9% had heard of daily oral PrEP, 76.9% had heard of event-driven PrEP, and only 21.7% had heard of CAB-LA. There were 44.5% of the ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet ...

Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...

Women under age 50 who consume higher amounts of ultraprocessed foods (UPFs) face significantly increased odds of developing ...

Jasmine Eugene, PharmD, explains how pharmacists practicing at the top of their license improve rural oncology access and ...

Patients seeking access to oral acute myeloid leukemia (AML) medications face complex insurance approval processes that can ...

Panelists discuss how managing oral therapy toxicities requires preemptive planning, multidisciplinary team involvement, ...